Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to $7.2 million.

  • Orthopediatrics' Accounts Payables fell 3849.06% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year decrease of 3849.06%. This contributed to the annual value of $8.9 million for FY2024, which is 2957.55% down from last year.
  • As of Q3 2025, Orthopediatrics' Accounts Payables stood at $7.2 million, which was down 3849.06% from $12.7 million recorded in Q2 2025.
  • In the past 5 years, Orthopediatrics' Accounts Payables registered a high of $22.6 million during Q3 2023, and its lowest value of $7.2 million during Q3 2025.
  • Over the past 5 years, Orthopediatrics' median Accounts Payables value was $12.6 million (recorded in 2023), while the average stood at $13.5 million.
  • In the last 5 years, Orthopediatrics' Accounts Payables soared by 10758.2% in 2023 and then tumbled by 4843.49% in 2024.
  • Orthopediatrics' Accounts Payables (Quarter) stood at $9.3 million in 2021, then increased by 19.57% to $11.2 million in 2022, then rose by 13.44% to $12.6 million in 2023, then dropped by 29.58% to $8.9 million in 2024, then fell by 19.58% to $7.2 million in 2025.
  • Its last three reported values are $7.2 million in Q3 2025, $12.7 million for Q2 2025, and $14.2 million during Q1 2025.